{{Rsnum
|rsid=11571302
|Chromosome=2
|position=203878211
|Orientation=minus
|GMAF=0.3779
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{PMID Auto
|PMID=19175525
|Title=CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data
|OA=1
}}
{{PMID Auto
|PMID=20537165
|Title=The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's disease
|OA=1
}}

{{PMID Auto
|PMID=17280620
|Title=CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden.
|OA=1
}}

{{PMID Auto
|PMID=18200060
|Title=PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not.
}}

{{PMID Auto
|PMID=18556337
|Title=Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1).
|OA=1
}}

{{PMID Auto
|PMID=19622768
|Title=CTLA4 variants, UV-induced tolerance, and risk of non-melanoma skin cancer.
|OA=1
}}

{{PMID Auto
|PMID=19672595
|Title=Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
|OA=1
}}

{{PMID Auto
|PMID=19740340
|Title=The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease.
|OA=1
}}

{{PMID Auto
|PMID=20352109
|Title=Association of the CTLA4 gene with Graves' disease in the Chinese Han population.
|OA=1
}}

{{PMID Auto
|PMID=21669243
|Title=CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}